CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Option exercise | +3,613 | $482.68 | $1.7M | 9,860 |
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Sale | −3,613 | $800.00 | $2.9M | 6,247 |
| 2023-02-06 | GOLDSTEIN JOSEPH L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,613 | 0 | ||
| 2023-02-06 | BROWN MICHAEL S Director | Option exercise | +3,071 | $520.01 | $1.6M | 4,318 |
| 2023-02-06 | BROWN MICHAEL S Director | Sale | −3,071 | $798.00 | $2.5M | 1,247 |
| 2023-02-06 | BROWN MICHAEL S Director | Sale | −500 | $797.00 | $399K | 6,162 |
| 2023-02-06 | BROWN MICHAEL S Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,071 | 3,070 | ||
| 2023-02-06 | YANCOPOULOS GEORGE President and Chief Scientific | Sale | −13,189 | $800.08 | $10.6M | 200,504 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −51 | $783.05 | $40K | 32,806 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −113 | $784.27 | $89K | 32,693 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −78 | $785.88 | $61K | 32,615 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −85 | $786.45 | $67K | 32,530 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −58 | $787.47 | $46K | 32,472 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −99 | $788.62 | $78K | 32,373 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −49 | $789.05 | $39K | 32,324 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −10 | $790.41 | $8K | 32,314 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −3 | $791.00 | $2K | 32,311 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −2 | $793.33 | $2K | 32,309 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −99 | $794.61 | $79K | 32,210 |
| 2023-02-06 | Landry Robert E EVP Finance CFO | Sale | −59 | $795.41 | $47K | 32,151 |
Page 57 of 105 · 2,088 trades